Showing results (781-790 of 988) with videos related to

Sort By:
Pageof 99
Annals of Surgical Oncology|February 2, 2018
Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue SarcomasEric Lu, Kelly S Perlewitz, James B Hayden, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 7, 2017
Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone lossYolandi Starczak, Daniel C Reinke, Kate R Barratt, et al.
Plos One|February 4, 2026
Variation in food web reliance on green and brown energy pathways across ecosystem gradientsJames W Sturges, W Ryan James, Ryan J Rezek, et al.
Environmental Science & Technology|April 2, 2020
Brown Carbon Production by Aqueous-Phase Interactions of Glyoxal and SO2David O De Haan, Kevin Jansen, Alec D Rynaski, et al.
Pediatric Blood & Cancer|September 28, 2012
Overcoming autopsy barriers in pediatric cancer researchJennifer L Alabran, Jody E Hooper, Melissa Hill, et al.
Angewandte Chemie (International Ed. in English)|February 15, 2023
Enhanced Four-Electron Oxygen Reduction Selectivity of Clamp-Shaped Cobalt(II) Porphyrin(2.1.2.1) ComplexesSonglin Xue, W Ryan Osterloh, Xiaojuan Lv, et al.
Annals of Emergency Medicine|February 15, 2016
Emergency Department Prescription Opioids as an Initial Exposure Preceding AddictionMegan M Butler, Rachel M Ancona, Gillian A Beauchamp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2025
Ribociblib in Sequential Combination with Doxorubicin in Anthracycline-Naive Advanced Soft Tissue Sarcomas: Results of a Dose-Finding Phase 1B StudyLara E Davis, Limin Zhu, Emile Latour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a study of the department of defense prostate cancer clinical trials consortiumJonathan E Rosenberg, Charles J Ryan, Vivian K Weinberg, et al.
Journal for Immunotherapy of Cancer|October 21, 2025
Multicenter phase II trial of ipilimumab and nivolumab in metastatic or unresectable perivascular epithelioid cell tumor (PEComa): a substudy of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609 (Cohort 38)Sandip P Patel, Megan Othus, Young K Chae, et al.
Pageof 99